These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 29849494)

  • 1. Mast Cells Exert Anti-Inflammatory Effects in an IL10
    Lennon EM; Borst LB; Edwards LL; Moeser AJ
    Mediators Inflamm; 2018; 2018():7817360. PubMed ID: 29849494
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mast cell deficiency exacerbates inflammatory bowel symptoms in interleukin-10-deficient mice.
    Zhang H; Xue Y; Wang H; Huang Y; Du M; Yang Q; Zhu MJ
    World J Gastroenterol; 2014 Jul; 20(27):9106-15. PubMed ID: 25083083
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of mast cells in inflammatory bowel disease and inflammation-associated colorectal neoplasia in IL-10-deficient mice.
    Chichlowski M; Westwood GS; Abraham SN; Hale LP
    PLoS One; 2010 Aug; 5(8):e12220. PubMed ID: 20808919
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor Necrosis Factor Receptor 2 Restricts the Pathogenicity of CD8(+) T Cells in Mice With Colitis.
    Punit S; Dubé PE; Liu CY; Girish N; Washington MK; Polk DB
    Gastroenterology; 2015 Oct; 149(4):993-1005.e2. PubMed ID: 26072395
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ig-free light chains play a crucial role in murine mast cell-dependent colitis and are associated with human inflammatory bowel diseases.
    Rijnierse A; Redegeld FA; Blokhuis BR; Van der Heijden MW; Te Velde AA; Pronk I; Hommes DW; Nijkamp FP; Koster AS; Kraneveld AD
    J Immunol; 2010 Jul; 185(1):653-9. PubMed ID: 20505143
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Defective IL10 signaling defining a subgroup of patients with inflammatory bowel disease.
    Begue B; Verdier J; Rieux-Laucat F; Goulet O; Morali A; Canioni D; Hugot JP; Daussy C; Verkarre V; Pigneur B; Fischer A; Klein C; Cerf-Bensussan N; Ruemmele FM
    Am J Gastroenterol; 2011 Aug; 106(8):1544-55. PubMed ID: 21519361
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The bone morphogenetic protein-hepcidin axis as a therapeutic target in inflammatory bowel disease.
    Wang L; Trebicka E; Fu Y; Ellenbogen S; Hong CC; Babitt JL; Lin HY; Cherayil BJ
    Inflamm Bowel Dis; 2012 Jan; 18(1):112-9. PubMed ID: 21351217
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chitosan oligosaccharide as potential therapy of inflammatory bowel disease: therapeutic efficacy and possible mechanisms of action.
    Yousef M; Pichyangkura R; Soodvilai S; Chatsudthipong V; Muanprasat C
    Pharmacol Res; 2012 Jul; 66(1):66-79. PubMed ID: 22475725
    [TBL] [Abstract][Full Text] [Related]  

  • 9. BMP signaling in rats with TNBS-induced colitis following BMP7 therapy.
    Maric I; Kucic N; Turk Wensveen T; Smoljan I; Grahovac B; Zoricic Cvek S; Celic T; Bobinac D; Vukicevic S
    Am J Physiol Gastrointest Liver Physiol; 2012 May; 302(10):G1151-62. PubMed ID: 22361727
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of murine and human Treg subsets in inflammatory bowel disease.
    Sun X; He S; Lv C; Sun X; Wang J; Zheng W; Wang D
    Mol Med Rep; 2017 Sep; 16(3):2893-2898. PubMed ID: 28677759
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A defect in epithelial barrier integrity is not required for a systemic response to bacterial antigens or intestinal injury in T cell receptor-alpha gene-deficient mice.
    Sydora BC; Tavernini MM; Doyle J; Fedorak RN
    Inflamm Bowel Dis; 2006 Aug; 12(8):750-7. PubMed ID: 16917231
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Loss of RHBDF2 results in an early-onset spontaneous murine colitis.
    Geesala R; Schanz W; Biggs M; Dixit G; Skurski J; Gurung P; Meyerholz DK; Elliott D; Issuree PD; Maretzky T
    J Leukoc Biol; 2019 Apr; 105(4):767-781. PubMed ID: 30694569
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD14 Plays a Protective Role in Experimental Inflammatory Bowel Disease by Enhancing Intestinal Barrier Function.
    Buchheister S; Buettner M; Basic M; Noack A; Breves G; Buchen B; Keubler LM; Becker C; Bleich A
    Am J Pathol; 2017 May; 187(5):1106-1120. PubMed ID: 28411859
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Critical role for mast cells in the pathogenesis of 2,4-dinitrobenzene-induced murine colonic hypersensitivity reaction.
    Rijnierse A; Koster AS; Nijkamp FP; Kraneveld AD
    J Immunol; 2006 Apr; 176(7):4375-84. PubMed ID: 16547276
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aberrant function of myeloid-derived suppressor cells (MDSCs) in experimental colitis and in inflammatory bowel disease (IBD) immune responses.
    Kontaki E; Boumpas DT; Tzardi M; Mouzas IA; Papadakis KA; Verginis P
    Autoimmunity; 2017 May; 50(3):170-181. PubMed ID: 28276713
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Composition of the Intestinal Microbiota Determines the Outcome of Virus-Triggered Colitis in Mice.
    Bolsega S; Basic M; Smoczek A; Buettner M; Eberl C; Ahrens D; Odum KA; Stecher B; Bleich A
    Front Immunol; 2019; 10():1708. PubMed ID: 31396223
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Colitis and intestinal inflammation in IL10-/- mice results from IL-13Rα2-mediated attenuation of IL-13 activity.
    Wilson MS; Ramalingam TR; Rivollier A; Shenderov K; Mentink-Kane MM; Madala SK; Cheever AW; Artis D; Kelsall BL; Wynn TA
    Gastroenterology; 2011 Jan; 140(1):254-64. PubMed ID: 20951137
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of BMPs and Wnt3a co-expression on the osteogenetic capacity of osteoblasts.
    Ruan W; Xue Y; Zong Y; Sun C
    Mol Med Rep; 2016 Nov; 14(5):4328-4334. PubMed ID: 27633082
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes in composition of caecal microbiota associated with increased colon inflammation in interleukin-10 gene-deficient mice inoculated with Enterococcus species.
    Bassett SA; Young W; Barnett MP; Cookson AL; McNabb WC; Roy NC
    Nutrients; 2015 Mar; 7(3):1798-816. PubMed ID: 25768951
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Angiogenesis blockade as a new therapeutic approach to experimental colitis.
    Danese S; Sans M; Spencer DM; Beck I; Doñate F; Plunkett ML; de la Motte C; Redline R; Shaw DE; Levine AD; Mazar AP; Fiocchi C
    Gut; 2007 Jun; 56(6):855-62. PubMed ID: 17170016
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.